WASHINGTON — Greater than 60 years after the approval of oral contraceptives revolutionized ladies’s sexual well being, the Meals and Drug Administration has acquired its first software to produce a contraception tablet over-the-counter — simply because the Supreme Court docket’s resolution to overturn Roe v. Wade has put entry to contraception extra squarely on the coronary heart of the conflict over reproductive rights.

A Paris-based firm, HRA Pharma, introduced on Monday that it had requested the F.D.A. to authorize its tablet, which is out there by prescription, for over-the-counter-sales in america. Cadence Well being, one other tablet producer that has been in shut dialogue with the F.D.A. about switching its tablet to over-the-counter standing, stated it hopes to maneuver nearer to submitting an software within the coming yr.

The timing of HRA Pharma’s F.D.A. submission, simply weeks after the Supreme Court docket resolution, is “a very unhappy coincidence,” stated Frédérique Welgryn, the corporate’s chief strategic and improvements officer. “Contraception just isn’t an answer for abortion entry,” she stated.

Underneath strange circumstances, submitting an software to promote a prescription drug over-the-counter would possibly go unnoticed in Washington. However contraception is a fragile subject for the F.D.A. Cadence and HRA Pharma have been mired for years within the company’s pre-application course of, and HRA’s formal software comes at an particularly fraught second within the marketing campaign for reproductive rights.

The Supreme Court docket’s ruling in Dobbs v. Jackson Ladies’s Well being Group, which struck down Roe and eradicated the constitutional proper to abortion, included a concurring resolution by Justice Clarence Thomas suggesting that the 1965 resolution that established a proper to contraception also needs to be overturned. On Friday, President Biden denounced the Dobbs ruling as “an train in uncooked political energy,” and vowed to increase entry to reproductive well being care.

On Capitol Hill, scores of Home Democrats signed a letter this yr to Robert Califf, the F.D.A. commissioner, requesting a “well timed assessment” of any functions to take birth-control drugs over-the-counter. Greater than 100 Democrats have signed on to a invoice requiring insurance coverage corporations to cowl the price of over-the-counter contraception. (The Inexpensive Care Act already requires insurers to cowl prescription contraceptives.)

“As we’re seeing the outfall and the chaos of the Supreme Court docket resolution, extra households wish to, ‘Properly, how can I make sure that I management my very own decisions in life?’” stated Senator Patty Murray, Democrat of Washington, the chairwoman of the Senate Well being Committee and the lead sponsor of the measure. “We wish to ensure that ladies not solely get entry, however those that have hassle affording it get entry as properly.”

HRA Pharma officers stated they anticipate an F.D.A. resolution in about 10 months, which is typical for over-the-counter functions. The F.D.A. declined to remark.

Supporters of reproductive rights are additionally calling on Mr. Biden to have the F.D.A. transfer shortly on its assessment of over-the-counter contraceptives in gentle of the Dobbs resolution. Dana Singiser, a founding father of the Contraceptive Entry Initiative, a nonprofit advocacy group, stated the expertise with Covid-19 confirmed that the F.D.A. “can work with urgency throughout a public well being emergency, which is what ladies are dealing with proper now with the overturning of Roe v. Wade.”

However Mr. Biden has taken a hands-off posture towards the F.D.A. Jen Klein, who advises the president on gender coverage, advised reporters on Friday that the company “has to undergo its course of.” And if historical past is any information, the trail to approval will likely be bumpy.

In 2011, the F.D.A. permitted the over-the-counter sale of Plan B, an emergency contraceptive, to youngsters 16 and youthful — solely to have Kathleen Sebelius, then the well being secretary within the Obama administration, take the exceedingly uncommon step of overruling its resolution after President Barack Obama expressed reservations about giving minors entry to the drug with out parental consent. Ms. Sebelius was ultimately overruled by a federal choose.

“Years of authorized wrangling lastly acquired them to observe the science,” stated Kelly Blanchard, the president of Ibis Reproductive Well being, a worldwide nonprofit group that partnered with HRA Pharma to conduct the analysis wanted to submit the applying. “We hope they observe the science and approve with out an age restriction on this case.”

However entry for youngsters is more likely to emerge as a sticking level. Leaders of the anti-abortion motion haven’t taken a place on over-the-counter contraception drugs, however they strongly oppose giving them to minors with none grownup involvement.

“I agree with Obama; it’s frequent sense to not recklessly promote these drugs,” stated Kristi Hamrick, a spokeswoman for College students for Life, an anti-abortion group. “As a father of two daughters, he understood that taking adults out of the equation is an issue.”

Roughly half of all pregnancies in america are unintended, in line with the Guttmacher Institute, a analysis group that helps abortion rights. Reproductive-rights activists view an over-the-counter contraception tablet as a simple and efficient device for folks in rural, poor and traditionally marginalized communities to keep away from undesirable pregnancies, which in flip reduces the abortion charge.

The Dobbs resolution has forged a highlight on the boundaries ladies, particularly poor ones, face in getting access to contraception — a degree that Representatives Barbara Lee of California and Diana DeGette of Colorado, the Democrats who chair the Home Professional-Selection Caucus, made in a letter they despatched to Dr. Califf in March.

“Regardless of many years of confirmed security and effectiveness, folks nonetheless face immense boundaries to getting contraception as a result of systemic inequities in our healthcare system,” stated the letter, additionally signed by 57 different Democrats. “These boundaries are disproportionately borne by folks of colour, immigrants, L.G.B.T.Q.+ folks, low-income people, younger folks and folks in rural communities.”

In a Might 18 reply, Dr. Califf wrote that the F.D.A. “acknowledges the general public well being advantages of elevated entry to oral contraceptives.” Selections on whether or not to approve over-the-counter standing for oral contraceptives, he stated, are “guided by the perfect accessible science.”

Younger folks, specifically, are longing for over-the-counter drugs, stated Angela Maske, who manages the #FreeThePill Youth Council, an advocacy group.

Ms. Maske, 25, stated she was denied contraception whereas a scholar at Georgetown College, a Catholic establishment whose scholar well being heart offers contraception if wanted for medical situations, corresponding to zits, “however indirectly for contraception,” in line with its web site.

The coverage, she stated, made her really feel as if she had been being inspired to lie, which “felt icky and immoral.” Over-the-counter drugs — which she famous can be found in additional than 100 international locations — would have solved the issue, she stated.

Medical specialists say that contraception drugs are among the many most secure and most-studied medicines in the marketplace, however that getting the mandatory prescription is usually a barrier to entry. A number of main medical organizations, together with the American Medical Affiliation, the American School of Obstetricians and Gynecologists and the American Academy of Household Physicians say that oral contraceptives are acceptable for over-the-counter use.

HRA Pharma’s tablet is a so-called mini tablet, that means it comprises solely the hormone progestin, which performs a job within the menstrual cycle and being pregnant.

The mini tablet is broadly utilized in Britain, however accounts for lower than 10 % of the U.S. marketplace for oral contraceptives, partly as a result of the drugs could cause unscheduled bleeding and require larger vigilance on the a part of sufferers, who should take them on the similar time each day. “Mixture drugs,” which embody each progestin and estrogen, are far more generally used.

“Oral contraceptives are secure, and they’re secure drugs for most individuals,” stated Dr. Jonas Swartz, an obstetrician and gynecologist at Duke College Well being System. “There’s good information that individuals can do screening with, both on-line instruments or checklists, to find out if they aren’t candidates for utilizing mixed drugs or progestin-only drugs.”

Each Cadence, which makes a mixture tablet, and HRA Pharma have been speaking with the F.D.A. for greater than six years about getting approval to promote their drugs over-the-counter. Cadence, which has not acquired F.D.A. approval to proceed with a medical trial that’s important to its software, might have to attend one other two years earlier than it will possibly achieve this.

Samantha Miller, the co-chief government of Cadence, stated the F.D.A. has put the corporate’s “precise use trial” — its examine to find out how ladies use the tablet in a real-world setting — on maintain. She stated the corporate is “actively working” with the company “to beat this regulatory hurdle by creating a user-friendly know-how interface for our over-the-counter product.”

HRA Pharma, which was just lately bought by Perrigo, a multinational maker of over-the-counter prescribed drugs primarily based in Dublin, already sells one other sort of progestin-only tablet over-the-counter in Britain, the place the drug is marketed underneath the identify Hana. In america, the prescription drug being thought-about for over-the-counter approval is known as Opill.

Value is sort of sure to be a difficulty. As a result of the Inexpensive Care Act requires insurers to cowl the expense of prescription contraceptives, individuals who have insurance coverage and are already taking Opill could also be loath to modify. Ms. Welgryn of HRA Pharma stated the corporate is set to make its product “very inexpensive for customers.” Cadence has made an identical promise.

Oral contraceptives had turn into entwined with the ladies’s rights motion even earlier than 1960, when the primary contraception tablet was permitted by the F.D.A. Within the Nineteen Forties and Fifties, Margaret Sanger, the founding father of Deliberate Parenthood, intently adopted analysis on contraception and funded a few of it herself, in line with a Deliberate Parenthood historical past.

The early drugs included excessive doses of hormones and carried the chance of negative effects; it took scientists greater than a decade to acknowledge these dangers and decrease the doses. Feminists had been “very longing for contraception, however very cautious concerning the first era of drugs,” stated Carole Joffe, a professor of obstetrics and gynecology on the College of California, San Francisco.

However the prospect of with the ability to separate intercourse from childbearing freed ladies to enter the office and to chart their very own skilled programs on their very own timetable — a growth that the Harvard economists, Claudia Goldin and Lawrence F. Katz, have known as the “energy of the tablet.”

However it was not till 1965, with the ruling within the landmark case of Griswold v. Connecticut, that the Supreme Court docket established a proper to contraception — after which just for married folks.

“It was revolutionary, as a result of in my grandmother’s age, that they had no decisions,” stated Senator Murray of Washington.

For many years, pharmaceutical corporations demonstrated little curiosity in providing contraception drugs over-the-counter. Oral contraceptives had been hardly blockbuster moneymakers, though if both HRA or Cadence turns into the primary to have its sort of tablet permitted for over-the-counter use it will likely be granted a brief monopoly on that market, meant to assist the corporate recoup analysis and growth prices.

Within the Eighties, an organization flirted with the thought, however deserted it, stated Dr. Daniel Grossman, an skilled in reproductive well being on the College of California, San Francisco. And the political and authorized battle over Plan B, he stated, gave pharmaceutical producers “chilly ft.”

“They noticed how even if you happen to had carried out the research precisely the way in which F.D.A. had laid them out,” he stated, “you can nonetheless get blocked for political causes.”